Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Cytokine & Growth Factor Reviews
|
August 19, 2007
Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma
Stergios Moschos, John M Kirkwood
Journal of Immunology (Baltimore, Md. : 1950)
|
March 8, 2005
Leptin in immunology
Giuseppe Matarese, Stergios Moschos, Christos S Mantzoros
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations
John M Kirkwood, Stergios Moschos, Wenjun Wang
Cancer Treatment and Research
|
October 8, 2005
Interferons in the treatment of solid tumors
Stergios Moschos, Sai Varanasi, John M Kirkwood
Fertility and Sterility
|
March 2, 2002
Leptin and reproduction: a review
Stergios Moschos, Jean L Chan, Christos S Mantzoros
Clinics in Dermatology
|
February 27, 2013
Historical review of melanoma treatment and outcomes
Carrie Lee, Frances Collichio, David Ollila, et al.
Dermatology Online Journal
|
August 3, 2010
A principal case of multiple lymphoid collision tumors involving both B-cell chronic lymphocytic leukemia and metastatic malignant melanoma
Aaron S Cantor, Stergios Moschos, Drazen M Jukic
Nephrology (Carlton, Vic.)
|
October 31, 2012
A 61 year diabetic man with methicillin-sensitive Staphylococcus aureus septic arthritis and acute renal failure: a case of IgA-dominant postinfectious glomerulonephritis
Sebhat Erqou, Nitin Kamat, Stergios Moschos, et al.
The Journal of Biological Chemistry
|
January 24, 2014
Induction of Gsk3β-β-TrCP interaction is required for late phase stabilization of β-catenin in canonical Wnt signaling
Chenxi Gao, Guangming Chen, Guillermo Romero, et al.
Cancer
|
August 23, 2008
A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma
Ahmad A Tarhini, John M Kirkwood, William E Gooding, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Cytokine & Growth Factor Reviews
|
August 19, 2007
Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma
Stergios Moschos, John M Kirkwood
Journal of Immunology (Baltimore, Md. : 1950)
|
March 8, 2005
Leptin in immunology
Giuseppe Matarese, Stergios Moschos, Christos S Mantzoros
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations
John M Kirkwood, Stergios Moschos, Wenjun Wang
Cancer Treatment and Research
|
October 8, 2005
Interferons in the treatment of solid tumors
Stergios Moschos, Sai Varanasi, John M Kirkwood
Fertility and Sterility
|
March 2, 2002
Leptin and reproduction: a review
Stergios Moschos, Jean L Chan, Christos S Mantzoros
Clinics in Dermatology
|
February 27, 2013
Historical review of melanoma treatment and outcomes
Carrie Lee, Frances Collichio, David Ollila, et al.
Dermatology Online Journal
|
August 3, 2010
A principal case of multiple lymphoid collision tumors involving both B-cell chronic lymphocytic leukemia and metastatic malignant melanoma
Aaron S Cantor, Stergios Moschos, Drazen M Jukic
Nephrology (Carlton, Vic.)
|
October 31, 2012
A 61 year diabetic man with methicillin-sensitive Staphylococcus aureus septic arthritis and acute renal failure: a case of IgA-dominant postinfectious glomerulonephritis
Sebhat Erqou, Nitin Kamat, Stergios Moschos, et al.
The Journal of Biological Chemistry
|
January 24, 2014
Induction of Gsk3β-β-TrCP interaction is required for late phase stabilization of β-catenin in canonical Wnt signaling
Chenxi Gao, Guangming Chen, Guillermo Romero, et al.
Cancer
|
August 23, 2008
A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma
Ahmad A Tarhini, John M Kirkwood, William E Gooding, et al.
Page
of 3